pumferi
et
al
proteom
virus
therefor
chapter
discuss
recent
find
proteom
dna
rna
viral
infect
associ
clinic
import
diseas
human
includ
human
cytomegaloviru
hcmv
herp
simplex
viru
hsv
epsteinbarr
viru
ebv
human
immunodefici
viru
hiv
hepat
b
c
hbv
hcv
respect
adenoviru
well
coronaviru
caus
sever
acut
respiratori
syndrom
sar
hcmv
largest
member
human
herpesvirus
initi
infect
hcmv
remain
persist
state
host
immun
viru
control
replic
although
intermitt
viral
shed
still
take
place
seroposit
immunocompet
person
replic
cytomegaloviru
absenc
effect
immun
respons
central
pathogenesi
diseas
complic
primarili
seen
individu
whose
immun
system
immatur
suppress
drug
treatment
coinfect
pathogen
estim
code
capac
hcmv
rang
open
read
frame
orf
orf
recent
studi
use
ms
determin
viral
proteom
suggest
number
viral
protein
may
even
greater
previou
estim
analysi
protein
purifi
hcmv
virion
prepar
indic
particl
contain
significantli
viral
protein
previous
known
hcmv
virion
protein
twelv
identifi
protein
encod
known
viral
orf
previous
associ
virion
protein
novel
viral
orf
therefor
new
protein
marker
includ
hcmv
tegument
variou
cellular
structur
protein
enzym
chaperon
serv
biomark
hcmv
infect
possibl
drug
target
herpesviru
member
also
explor
presenc
possibl
biomark
ebv
ubiquit
member
herpesviru
famili
associ
varieti
lymphoma
lymphoprolif
diseas
encod
multitud
gene
drive
prolifer
confer
resist
cell
death
infect
human
b
lymphocyt
ebv
induc
prolif
blymphoblastoid
cell
line
lcl
recent
proteom
profil
three
lcl
analyz
compar
earli
late
passag
cell
cultur
phosphoprotein
stathmin
identifi
express
significantli
decreas
immort
lcl
stathmin
critic
import
format
normal
mitot
spindl
upon
entri
mitosi
also
regul
function
mitot
spindl
later
stage
mitosi
time
exit
mitosi
anoth
studi
use
standard
matrixassist
laser
desorptionion
timeofflight
malditof
method
target
protein
identifi
cmyc
depend
therefor
probabl
associ
prolifer
host
cell
find
stress
role
ebv
viral
protein
name
ebna
lmp
diseas
pathogenesi
interestingli
ebvinfect
cell
treat
drug
azc
demethyl
agent
induc
express
silenc
gene
ie
tumor
suppressor
polypeptid
downregul
pumferi
et
al
term
proteom
first
coin
late
marc
wilkin
siena
twodimension
gel
electrophoresi
meet
defin
entir
protein
complement
given
cell
tissu
organ
wider
sens
proteom
research
also
assess
protein
activ
modif
local
interact
protein
complex
reli
heavili
technolog
sinc
need
identifi
protein
protein
complex
biolog
sampl
comprehens
quantit
high
sensit
fidel
proteom
promis
approach
studi
virus
allow
better
understand
diseas
process
develop
new
biomark
diagnosi
earli
detect
diseas
acceler
drug
develop
area
proteom
particularli
promis
includ
determin
alter
protein
express
wholecel
tissu
level
also
subcellular
structur
biolog
fluid
develop
novel
biomark
diagnosi
earli
detect
diseas
identif
new
target
therapeut
potenti
acceler
drug
develop
effect
strategi
evalu
therapeut
effect
toxic
grow
interest
appli
proteom
studi
infecti
diseas
complic
factor
therapi
infecti
diseas
develop
resist
commonli
use
drug
heighten
need
develop
effect
new
therapi
avail
complet
sequenc
number
virus
provid
framework
identifi
protein
encod
genom
use
mass
spectrometri
ms
appli
proteom
studi
virus
allow
character
subvir
proteom
eg
secret
protein
surfac
protein
immunogen
protein
compar
analysi
differ
stain
physiolog
state
identif
protein
relat
pathogen
hostpathogen
interact
evalu
mechan
action
antivir
therapi
viral
infect
caus
signific
morbid
diseas
includ
cancer
immunosuppress
death
often
infect
diagnos
symptom
appear
sever
case
may
year
decad
initi
infect
abil
diagnos
infect
cancer
appear
symptom
would
critic
import
effect
treatment
proteom
analysi
serum
propos
mean
diagnos
infecti
diseas
andor
earli
diagnosi
cancer
recent
excit
find
proteom
host
pathogen
use
standard
mass
spectrometr
technolog
enabl
mani
physician
scientist
examin
close
patholog
biolog
question
answer
use
proteom
approach
show
increas
express
mani
induc
protein
involv
energi
metabol
organ
cytoskelet
structur
protein
synthesi
cell
viabil
therefor
effect
drug
activ
silenc
tumor
suppressor
gene
proteom
profil
follow
treatment
consider
interest
final
import
herpesviru
consid
hsv
hsv
type
ubiquit
virus
caus
infect
human
popul
throughout
world
clinic
manifest
hsv
infect
vari
rang
asymptomat
lifethreaten
ill
neonat
immunocompromis
host
infect
induc
sever
alter
host
translat
apparatu
includ
phosphoryl
ribosom
protein
progress
associ
sever
nonribosom
protein
ribosom
use
proteom
approach
shown
associ
ribosom
protein
specif
immedi
earli
protein
associ
cellular
translat
initi
factor
poli
bind
protein
pabp
eukaryot
initi
factor
eukaryot
initi
factor
infect
cell
result
stimul
translat
certain
viral
mrna
inhibit
host
mrna
translat
anoth
studi
shown
approxim
cellular
viral
protein
associ
singlestrand
dnabind
protein
belong
dna
repair
chromatin
famili
member
impli
infect
result
control
host
cellular
dna
replicationrepair
gene
express
machineri
proteom
analys
rna
virus
regard
diagnosi
novel
biomark
detect
also
consider
interest
medic
commun
instanc
sar
new
infecti
diseas
first
emerg
guangdong
provinc
china
novemb
novel
coronaviru
later
identifi
patient
sar
detect
viru
patient
absenc
healthi
control
patient
atyp
pneumonia
reproduct
similar
diseas
relev
anim
model
indic
coronaviru
caus
agent
sar
sarscov
interestingli
full
genom
sequenc
determin
within
week
identif
viru
proteom
biomark
associ
sar
slowli
forthcom
recent
studi
use
mass
spectrometr
decis
tree
classif
algorithm
kang
et
al
identifi
four
biomark
determin
train
set
could
precis
detect
sensit
acut
sar
specif
nonsar
sampl
reason
complet
proteom
analysi
also
perform
four
patient
sar
differ
time
infect
total
differenti
spot
select
protein
identif
protein
identifi
acut
phase
protein
presenc
repres
consequ
serial
cascad
inflammatori
reaction
initi
sarscov
infect
signific
level
plasma
peroxiredoxin
ii
patient
sar
significantli
higher
sar
patient
could
secret
cell
final
pursu
new
enzym
target
anoth
studi
identifi
put
orf
predict
express
nest
set
eight
subgenom
mrna
distant
homolog
cellular
rna
process
enzym
identifi
group
coronavirus
four
conserv
sarscov
newli
recogn
viral
enzym
put
mechan
coronaviru
rna
synthesi
complet
new
perspect
open
door
new
drug
target
treatment
sar
proteom
three
rna
virus
includ
hcv
hbv
also
studi
hepat
c
often
progress
chronic
infect
major
patient
emerg
caus
viral
hepat
clinic
infect
gener
asymptomat
may
present
wide
varieti
symptom
cirrhosi
hepatocellular
carcinoma
hcc
cryoglobulinemia
autoantibodi
glomerulonephr
strongli
associ
hcv
infect
analyz
protein
interact
hcv
protein
choi
et
al
found
cytoplasm
heat
shock
protein
bound
concentr
er
drug
hcv
treatment
would
easi
access
oppos
drug
deliv
nucleu
chronic
infect
hbv
associ
major
hcc
use
woodchuck
model
system
hcc
induc
dramat
higher
level
serumassoci
core
fucos
compar
woodchuck
without
hcc
coupl
model
system
gel
electrophoresi
permit
identif
sever
glycoprotein
alter
glycosyl
correl
cancer
prognosi
one
glycoprotein
golgi
protein
found
elev
hyperfucosyl
anim
hcc
final
effort
identifi
use
biomark
hbvor
hcvassoci
hcc
protein
identifi
exhibit
signific
chang
express
nontumor
tumor
tissu
among
protein
commonli
chang
three
hcc
type
protein
show
tendenc
toward
viral
marker
specif
suggest
pathogen
mechan
hepatocarcinogenesi
may
differ
accord
viral
etiolog
hbv
hcv
diagnosi
treatment
strategi
hcv
becom
extrem
import
onethird
hivinfect
individu
europ
usa
coinfect
hcv
therefor
defin
biomark
coinfect
highli
activ
antiretrovir
therapi
haart
current
focu
mani
laboratori
hiv
acceler
hcv
liver
diseas
especi
progress
hivassoci
immunodefici
introduct
pegyl
interferon
combin
ribavirin
greatli
improv
treatment
option
patient
coinfect
hiv
hcv
becom
avail
led
sustain
virolog
respons
rate
furthermor
recent
cohort
analys
shown
immun
reconstitut
induc
haart
improv
cours
hepat
c
infect
lead
declin
liverrel
mortal
howev
patient
hcv
coinfect
increas
risk
hepatotox
haart
owe
high
rate
hiv
hcv
coinfect
worldwid
new
improv
biomark
treatment
strategi
guidelin
manag
coinfect
remain
major
goal
biomark
could
includ
protein
fingerprint
human
monocytederiv
macrophag
mdm
viral
infect
well
hcvinfect
liver
cell
recent
protein
alreadi
identifi
upor
downregul
infect
overal
awar
import
protein
peptid
physiolog
pathophysiolog
increas
dramat
last
year
progress
analysi
whole
genom
knowledg
base
gene
sequenc
express
data
use
protein
peptid
analysi
increas
consider
therefor
medic
need
relev
biomark
enorm
particularli
true
mani
viral
infect
variou
type
cancer
lack
use
adequ
diagnost
marker
high
specif
sensit
howev
proteom
peptidebas
techniqu
evolv
recent
year
simplifi
search
biomark
peptidebas
technolog
provid
new
opportun
detect
lowmolecularweight
protein
biomark
peptid
ms
improv
peptidebas
research
base
separ
peptid
andor
protein
physicochem
properti
combin
mass
spectrometr
detect
identif
use
sophist
bioinformat
tool
data
analysi
therefor
peptidebas
technolog
offer
opportun
discov
novel
biomark
diagnosi
manag
diseas
includ
prognosi
treatment
decis
monitor
respons
therapi
number
critic
viral
infect
domin
research
biomark
landscap
mani
find
reli
somewhat
simpl
shelf
technolog
fairli
straightforward
use
perhap
simplest
technolog
surfaceenhanc
laser
desorptionion
seldi
technolog
studi
sar
detect
kang
et
al
develop
mass
spectrometr
decis
tree
classif
algorithm
use
selditof
ms
serum
sampl
group
acut
sar
nonsar
healthi
control
cohort
dilut
sampl
appli
proteinchip
array
ciphergen
bound
protein
assess
proteinchip
reader
model
pb
ii
result
clearli
indic
impress
accuraci
discriminatori
classifi
anoth
similar
studi
indic
nine
serum
marker
significantli
increas
three
significantli
decreas
sar
patient
compar
control
anoth
proteinchip
assay
use
studi
infect
show
uniqu
mdm
protein
fingerprint
hivassoci
dementia
haart
seven
uniqu
protein
peak
kda
found
mdm
sampl
abrog
haart
similar
studi
use
specif
protein
produc
monocyt
patient
show
total
protein
peak
kda
mdm
lysat
select
protein
peak
da
separ
subject
sensit
specif
howev
viral
proteom
studi
date
util
either
malditof
ms
lcmsm
hiv
virion
compos
lipid
bilay
surround
viral
capsid
fig
clever
studi
fuchigami
et
al
studi
particl
collect
ultracentrifug
treat
subtilisin
purifi
sepharos
column
chromatographi
remov
microvesicl
lysat
purifi
particl
subject
stain
stain
spot
excis
digest
trypsin
result
peptid
fragment
character
malditof
ms
twentyf
protein
identifi
protein
insid
virion
acidlabil
formyl
group
amino
termin
prolin
residu
gag
determin
malditof
ms
weakacid
treatment
n
hydrochlor
acid
confirm
postsourc
decay
psd
nformyl
ntermin
tryptic
peptid
nformyl
pro
arg
interestingli
formyl
play
critic
role
format
core
confer
infect
recent
use
liquid
chromatographi
tandem
ms
lcmsm
also
eas
purif
recoveri
method
instanc
varnum
colleagu
util
gelfre
twodimension
capillari
lcmsm
fourier
transform
ion
cyclotron
reson
ms
identifi
determin
rel
abund
viral
cellular
protein
purifi
hcmv
virion
dens
bodi
analysi
protein
purifi
hcmv
virion
prepar
indic
particl
contain
significantli
viral
protein
previous
known
identifi
hcmvencod
protein
host
cellular
protein
hcmv
virion
includ
cellular
structur
protein
enzym
chaperon
anoth
studi
use
lcmsm
adenoviru
type
proteom
found
total
protein
speci
peptid
sensit
copi
per
viru
detect
limit
fmol
two
protein
two
new
method
use
recent
deciph
viral
proteom
method
proteolyt
stabl
isotop
label
recent
use
provid
quantit
concurr
comparison
individu
protein
two
differ
proteom
pool
subfract
use
techniqu
two
atom
incorpor
univers
carboxyl
termini
tryptic
peptid
proteolyt
cleavag
protein
first
pool
protein
second
pool
analog
cleav
carboxyl
termini
result
peptid
contain
two
atom
ie
label
method
use
compar
two
viru
strain
adenoviru
type
shotgun
approach
proteom
studi
quantit
capabl
may
power
tool
compar
proteom
studi
complex
protein
mixtur
final
isotopecod
affin
tag
icat
procedur
also
yield
interest
result
rather
complex
viral
infect
set
instanc
protein
human
liver
carcinoma
cell
repres
transform
liver
cell
cultur
primari
human
fetal
hepatocyt
hfh
extract
process
icat
chromatographi
protein
hepat
c
virusinfect
cell
correspond
control
cell
label
light
heavi
cleavabl
icat
reagent
respect
label
sampl
combin
trypsin
subject
cationexchang
avidinaffin
chromatographi
result
cysteinecontain
peptid
analyz
microcapillari
lcmsm
use
sequest
bioinformat
softwar
total
protein
relat
protein
group
identifi
three
subdataset
uninfect
infect
cell
collect
result
emphas
new
target
biomark
drug
develop
hcv
infect
describ
new
technolog
collect
ad
arsen
possibl
biomark
diagnos
variou
viral
infect
howev
mani
marker
still
need
valid
use
rigor
sampl
method
biolog
biochem
test
sophist
bioinformat
tool
bioinformat
tool
valuabl
viral
diagnosi
fast
retriev
dna
protein
sequenc
includ
orfer
program
http
wwwproteinstrukturfabrikdeorf
proteom
databas
http
proteomebtcnusedusghccm
poxviru
proteom
databas
http
virgen
http
bioinfoernetinvirgenvirgenhtml
chapter
explor
import
proteom
studi
virushost
interact
sever
viral
system
includ
hcmv
kshv
ebv
hsv
hcv
also
describ
method
employ
studi
viral
diseas
progress
use
sever
techniqu
includ
lcmsm
seldi
protein
microarray
viral
proteom
includ
analysi
viral
particl
determin
proteinsvir
cellularthat
compos
infecti
viru
examin
cellular
protein
associ
singl
viral
protein
hope
determin
function
viral
protein
determin
cellular
protein
induc
alter
particular
diseas
state
identif
viral
protein
requir
viral
genom
fulli
sequenc
potenti
orf
identifi
present
differ
viral
genom
sequenc
annot
deposit
public
sequenc
databas
genbank
embl
ddbj
addit
nation
center
biotechnolog
inform
ncbi
establish
viral
genom
project
provid
standard
viral
genom
research
resourc
research
viru
proteom
viral
proteom
sever
herpesvirus
hepat
c
viru
human
pumferi
et
al
hiv
analyz
review
viral
particl
hcmv
kaposi
sarcomaassoci
herpesvirushuman
herpesviru
recent
examin
herpesvir
replic
cycl
differ
viral
particl
form
hcmv
includ
matur
infecti
virion
noninfecti
envelop
particl
dens
bodi
similarli
kshv
portion
produc
viru
particl
infecti
therefor
analysi
infecti
virion
requir
separ
noninfecti
immatur
form
densiti
ultacentrifug
gradient
typic
use
separ
variou
form
fraction
analyz
electron
microscopi
determin
level
puriti
assay
viral
dna
envelop
glycoprotein
herpesvirus
larg
envelop
dna
virus
fig
viral
particl
consist
lipid
envelop
embed
viral
glycoprotein
import
infect
target
cell
envelop
surround
amorph
proteinac
structur
call
tegument
tegument
often
compos
viral
protein
critic
initi
viral
gene
express
exampl
protein
hsv
well
viral
cellular
protein
whose
function
unknown
tegument
surround
viral
capsid
compos
major
capsid
protein
one
minor
capsid
protein
viral
dna
identif
tegument
capsid
protein
differenti
envelop
glycoprotein
differenti
sensit
trypsin
deterg
tegument
capsid
protein
resist
trypsin
digest
absenc
deterg
envelop
glycoprotein
howev
sensit
trypsin
digest
whether
deterg
present
howev
surfaceexpos
portion
glycoprotein
sensit
trypsin
absenc
deterg
follow
gradient
purif
virion
lc
ms
ms
use
identifi
compon
hcmv
virion
result
verifi
coupl
highaccuraci
mass
measur
lc
fticr
fourier
transform
ion
cyclotron
reson
ms
fiftynin
protein
identifi
includ
protein
encod
known
hcmv
orf
previous
known
resid
virion
class
protein
identifi
includ
capsid
protein
tegument
protein
glycoprotein
protein
involv
dna
replic
transcript
addit
viral
polypeptid
identifi
previous
character
use
intens
fticr
spectra
rel
quantiti
virion
protein
determin
indic
virion
compos
tegument
protein
capsid
protein
envelop
protein
undefin
protein
undefin
protein
like
cellular
protein
incorpor
virion
host
cellular
protein
detect
comparison
peptid
predict
humanfasta
databas
cellular
protein
identifi
associ
hcmv
virion
includ
cytoskelet
protein
protein
involv
translat
control
sever
signal
transduct
protein
identif
cellular
protein
involv
translat
signal
transduct
compon
hcmv
virion
suggest
protein
may
function
initi
viral
gene
express
induc
environ
suitabl
hcmv
infect
kshv
fulli
sequenc
last
year
therefor
much
known
composit
viru
particl
nealon
et
al
use
sdspolyacrylamid
gel
electrophoresi
page
western
blot
identifi
major
capsid
scaffold
protein
compon
isol
virion
use
ion
trap
ms
identifi
three
addit
compon
virion
orf
studi
howev
limit
unabl
identifi
compon
infecti
viru
zhu
et
al
use
comprehens
approach
identifi
virion
compon
extracellular
virion
purifi
doubl
gradient
centrifug
sdspage
reveal
protein
band
whose
ident
determin
ingel
trypsin
digest
follow
lc
ms
peptid
mass
peptid
sequenc
produc
tandem
ms
msm
use
determin
protein
ident
isol
protein
includ
five
capsid
protein
eight
glycoprotein
six
tegument
protein
five
kshv
orf
twenti
cellular
protein
also
identifi
seen
hcmv
includ
cytoskelet
protein
signal
transduct
protein
well
heat
shock
protein
similar
result
seen
studi
bechtel
et
al
howev
fewer
protein
identifi
studi
singl
sdspage
gel
use
separ
virion
protein
zhu
et
al
use
three
sdspage
gela
gel
gel
separ
protein
larger
kda
gel
separ
protein
smaller
kda
studi
underscor
need
good
separ
method
abl
identifi
protein
viru
particl
epsteinbarr
viru
ebv
bcell
lymphotrop
herpesviru
induc
usual
asymptomat
infect
carri
adult
howev
ebv
caus
agent
burkitt
lymphoma
nasopharyng
carcinoma
involv
number
acquir
immunodefici
syndrom
aid
associ
lymphoma
ebv
induc
immort
b
cell
vitro
gener
lymphoblastoid
cell
line
lcl
model
carcinogen
potenti
ebv
lcl
latent
infect
ebv
maintain
viru
extrachromosom
episom
limit
viral
gene
express
latent
express
protein
six
ebv
nuclear
antigen
ebna
lp
three
latent
membran
protein
lmp
latent
express
protein
lmp
requir
transform
induc
ebv
character
cellular
protein
associ
protein
differenti
express
earli
stage
transform
process
describ
follow
text
result
studi
may
lead
better
understand
ebvmedi
transform
identif
cellular
target
therapi
proteom
databas
lcl
transform
develop
identifi
cellular
mechan
virusinduc
immort
use
first
separ
protein
base
rel
charg
pi
base
molecular
weight
differenti
express
protein
digest
subject
electrospray
ioniz
ms
protein
identifi
base
peptid
mass
fingerprint
amino
acid
sequenc
peptid
determin
edman
degrad
differenti
express
protein
assign
known
protein
express
sever
protein
involv
prolifer
nucleotid
metabol
increas
immort
cell
may
result
growth
stimul
seen
immort
cell
databas
gel
imag
well
ident
differenti
express
protein
made
avail
public
avail
imag
identif
differenti
express
protein
may
prove
use
other
analysi
ebvinfect
cell
requir
transform
lcl
ebv
induc
express
cmyc
cmyc
oncogen
drive
cell
prolifer
howev
prolifer
program
induc
cmyc
differ
observ
express
suggest
cellular
protein
event
induc
mediat
transform
furthermor
limit
inform
cellular
target
identifi
chang
cmyc
depend
cmyc
independ
cmyccondit
express
cell
line
use
proteom
cell
line
compar
protein
separ
sdspage
identifi
malditof
ms
express
cell
differenti
express
protein
induc
repress
protein
induc
follow
express
sever
involv
nucleotid
metabol
protein
synthesi
control
apoptosi
mani
protein
also
induc
cmyc
express
cell
though
six
protein
found
specif
two
protein
induc
bid
igehrf
four
repress
annexin
iv
furthermor
analysi
activ
kinet
demonstr
express
preced
cmyc
follow
express
nucleotid
diphosph
kinas
may
suppress
metastasi
indic
cmyc
direct
target
herp
simplex
viru
hsv
extens
studi
human
herpesvirus
owe
abil
easili
infect
cell
vitro
produc
infecti
viru
herpesvirus
hsv
encod
number
protein
effici
viral
gene
express
viral
dna
replic
shutoff
cellular
gene
transcript
translat
viral
express
protein
function
isol
associ
varieti
cellular
viral
protein
furthermor
mani
exhibit
multipl
differ
function
effort
understand
biolog
hsv
function
protein
proteom
approach
use
studi
critic
viral
transactiv
alter
cellular
translat
machineri
compon
viral
replic
complex
review
protein
express
earli
infect
essenti
viral
replic
express
certain
earli
gene
virtual
late
gene
multifunct
protein
may
function
virion
host
shutoff
vh
protein
hsv
repress
cellular
protein
synthesi
repress
serv
direct
cellular
resourc
synthesi
viral
protein
use
immunoprecipit
hsvinfect
cell
follow
sdspage
ms
sever
translat
initi
factor
identifi
includ
pabp
interact
translat
initi
factor
may
recruit
factor
viral
mrna
facilit
translat
viral
mrna
also
sequest
factor
away
translat
cellular
mrna
hsv
infect
also
induc
ribosom
chang
hypothes
chang
may
contribut
hsvmediat
translat
control
host
viral
gene
express
identifi
chang
ribosom
follow
hsv
infect
ribosom
purifi
ultracentrifug
protein
separ
sdspage
ident
determin
malditof
ms
seven
addit
protein
spot
found
associ
ribosom
follow
hsv
infect
includ
sever
viral
protein
viral
capsid
tegument
protein
three
seven
spot
phosphoryl
form
one
nonribosom
protein
pabp
also
found
associ
ribosom
associ
pabp
ribosom
increas
follow
hsv
infect
interestingli
pabp
also
found
associ
previou
studi
although
greco
et
al
find
associ
ribosom
like
due
differ
separ
procedur
use
greco
et
al
use
focus
sole
basic
protein
pi
greater
fontainerodriguez
et
al
separ
isol
protein
base
molecular
weight
togeth
result
suggest
like
associ
ribosom
infect
cell
herpesviru
dna
replic
occur
intranuclear
structur
call
replic
compart
hsv
encod
seven
protein
particip
viral
dna
replic
howev
known
cellular
protein
involv
process
identifi
cellular
protein
hsv
replic
compart
hsv
singlestrand
dnabind
protein
immunoprecipit
infect
cell
coprecipit
protein
separ
sdspage
identifi
ion
trap
ms
greater
viral
cellular
protein
identifi
copurifi
cellular
protein
includ
particip
dna
replicationrepairrecombin
chromatin
remodel
rna
bindingspl
transcript
factor
sever
protein
requir
dna
bind
associ
includ
sever
chromatinremodel
protein
role
number
interact
cellular
protein
present
unclear
studi
need
determin
exact
role
viral
dna
replic
hiv
encod
critic
transcript
activ
tat
direct
cellular
transcript
factor
ptefb
hiv
ltr
mediat
transcript
elong
howev
shown
viral
genom
bound
nucleosom
inhibit
viral
gene
express
determin
tat
interact
addit
cellular
protein
assist
viral
gene
express
use
tat
peptid
link
biotin
pull
tatassoci
protein
addit
acetyl
unmodifi
peptid
also
use
acetyl
tat
attribut
altern
function
tat
found
mani
cellular
protein
bound
unmodifi
tat
includ
protein
involv
modif
chromatin
structur
pcaf
addit
transcript
factor
trim
famili
memberand
scla
bhlh
transcript
factor
result
indic
tat
influenc
viral
gene
express
variou
level
suggest
target
specif
interact
may
viabl
form
treatment
hiv
infect
aid
hiv
infect
sever
cell
type
cours
infect
progress
aid
hivinfect
patient
viru
establish
persist
infect
cell
monocytemacrophag
lineag
monocyt
macrophag
first
line
defens
immun
system
phagocytos
kill
rang
microorgan
howev
littl
know
hiv
persist
cell
understand
hiv
may
persist
cell
carlson
et
al
use
proteinchip
seldi
identifi
uniqu
protein
signatur
hivinfect
monocyt
obtain
differ
donor
infect
monocyt
isol
human
use
mimic
virushost
interact
would
occur
infect
individu
proteinchip
use
studi
use
partial
purifi
sampl
one
weak
cation
exchang
second
reversephas
hydrophob
interact
chip
charg
protein
bind
cation
ionexchang
chip
hydrophob
ie
membraneassoci
protein
bind
reversephas
chip
protein
bound
chip
analyz
ms
peak
repres
protein
particular
mass
howev
natur
protein
peak
seldi
ms
unknown
differ
separ
technolog
ms
need
determin
protein
ident
determin
ident
protein
upor
downregul
follow
hiv
infect
monocyt
total
protein
extract
subject
trypsin
digest
lc
tandem
ms
determin
sequenc
tryptic
peptid
sequenc
analyz
protein
bank
determin
ident
protein
given
score
problem
type
studi
quantit
assess
increas
decreas
protein
level
chang
posttransl
modif
ptm
follow
infect
affect
almost
onethird
adult
infect
hiv
exact
caus
dementia
known
signific
neuron
loss
neuron
infect
hiv
hypothes
hivinfect
astrocyt
critic
develop
hiv
dementia
tat
contributor
diseas
extracellular
tat
releas
astrocyt
induc
cell
death
neuron
though
tat
protect
astrocyt
cell
death
understand
dichotomi
protein
differenti
express
tatexpress
astrocyt
identifi
total
protein
extract
tatexpress
control
cell
separ
gel
electrophoresi
identifi
maldi
ms
interestingli
seven
protein
found
repress
tat
astrocyt
includ
rho
gdp
dissoci
inhibitor
protein
phosphatas
inhibitor
mani
protein
shown
involv
biolog
hiv
interact
tat
three
protein
identifi
slot
blot
techniqu
found
induc
includ
heme
oxygenas
induc
nitric
oxid
synthas
ino
previous
publish
data
demonstr
correl
ino
sever
howev
role
differenti
express
protein
astrocyt
surviv
hiv
dementia
requir
studi
human
tcell
leukemia
viru
type
caus
adult
tcell
leukemia
atl
myelopathytrop
spastic
paraparesi
ham
tsp
encod
transactiv
tax
critic
viru
replic
play
central
role
develop
atl
hamtsp
tax
bind
dna
directli
function
interact
varieti
cellular
protein
mani
proteinprotein
interact
tax
determin
mutat
analysi
includ
creb
nfb
identifi
cellular
protein
interact
tax
wu
et
al
use
chromatographi
gel
electrophoresi
mass
spectrometr
analysi
cell
line
tax
function
cytoplasm
nucleu
taxinteract
protein
identifi
cellular
compart
cytoplasm
protein
includ
small
gtpase
compon
cytoskeleton
interest
nuclear
protein
includ
compon
swisnf
chromatin
remodel
complex
interact
tax
mani
identifi
cellular
protein
may
involv
abil
tax
dysregul
cellular
function
lead
tcell
transform
leukemia
hepatocellular
carcinoma
hcc
caus
approxim
one
million
death
year
two
virus
main
caus
hcc
hbv
hcv
although
hbv
import
caus
hcc
account
hcc
case
effect
vaccin
avail
hcv
howev
major
caus
increas
incid
hcc
develop
countri
effect
vaccin
avail
hcc
progress
decad
chronic
infect
often
advanc
stage
present
clinic
good
noninvas
diagnost
marker
need
discuss
section
focu
section
identif
cellular
protein
induc
follow
hcv
infect
cellular
protein
interact
hcv
protein
extens
studi
wirth
et
al
analyz
normal
liver
tissu
hepatomaderiv
cell
line
gel
electrophoresi
ntermin
sequenc
identifi
number
protein
differenti
express
normal
tissu
hepatoma
cell
line
similar
studi
perform
other
well
howev
studi
use
cell
line
cultur
may
accur
reflect
chang
seen
hcc
comparison
liver
tumor
tissu
normal
tissu
would
ideal
howev
tissu
heterogen
issu
could
confound
result
recent
infecti
cell
cultur
model
hcv
avail
new
model
system
allow
identif
cellular
protein
induc
follow
hcv
infect
develop
treatment
hcv
hcv
genom
encod
larg
polyprotein
cleav
gener
protein
includ
core
envelop
protein
nonstructur
protein
propos
act
cofactor
hcv
replic
transcript
activ
antiapoptot
factor
identifi
cellular
protein
interact
choi
et
al
coimmunoprecipit
protein
use
antisera
separ
via
gel
electrophoresi
determin
ident
ms
one
cellular
protein
found
interact
specif
heat
shock
protein
hsp
also
known
analysi
indic
interact
ctermin
domain
protein
shown
coloc
around
nucleu
hsp
induc
follow
cellular
stress
protect
cell
apoptosi
yet
overexpress
protect
cell
hcv
coreinduc
apoptosi
express
could
reduc
sirna
role
hcv
rna
replic
could
determin
howev
due
multifunct
natur
surpris
one
protein
found
interact
antibodi
use
coimmunoprecipit
cellular
protein
antibodi
use
studi
may
interf
bind
cellular
protein
problem
may
overcom
use
differ
antibodi
use
tag
affin
chromatographi
proteom
analysi
provid
uniqu
tool
identif
diagnost
biomark
evalu
diseas
progress
drug
develop
also
import
approach
clinic
diagnost
fact
earli
diagnosi
diseas
could
possibl
use
uniqu
protein
profil
consist
panel
biomark
serv
surrog
marker
diseas
novel
diagnost
test
may
gener
proteom
discoveri
mani
protein
identifi
potenti
drug
target
biomark
like
serv
multipl
purpos
includ
assess
drug
efficaci
drug
toxic
diagnosi
review
variou
methodolog
use
viral
diagnost
discuss
advantag
disadvantag
techniqu
classic
proteom
platform
includ
ms
employ
separ
protein
mixtur
first
dimens
isoelectr
point
second
dimens
molecular
mass
result
gel
stain
varieti
protein
dye
reveal
pattern
spot
first
dimens
isoelectr
focus
ief
perform
use
ipg
strip
base
use
bifunct
immobilin
reagent
seri
chemic
welldefin
acrylamid
deriv
copolymer
acrylamid
matrix
gener
extrem
stabl
ph
gradient
form
seri
buffer
differ
pk
valu
subsequ
linear
nonlinear
wide
ipg
medium
ipg
narrow
ipg
ultranarrow
ipg
ph
rang
ipg
cast
suggest
reader
refer
review
gorg
et
al
detail
ipg
strip
rehydr
sampl
applic
ipg
strip
equilibr
second
dimens
consist
use
sdspage
separ
protein
accord
molecular
weight
howev
analysi
lowmolecularweight
kda
highmolecularweight
kda
protein
challeng
sinc
standard
system
effect
allow
separ
protein
entir
rang
kda
common
approach
combin
sever
gel
optim
differ
molecular
weight
rang
instead
use
singl
standard
system
current
method
diagnosi
hcc
reli
serolog
marker
afp
certain
liver
enzym
well
de
gamma
carboxyprothrombin
dcp
type
diagnosi
lack
sensit
detect
hcc
earli
stage
therapi
effect
find
marker
diseas
progress
employ
resolv
compar
protein
present
serum
obtain
individu
infect
hbv
hcv
vari
risk
develop
hcc
sever
studi
protein
express
differ
level
among
diseas
individu
compar
healthi
one
identifi
marker
diseas
progress
well
protein
differ
nglycosyl
pattern
anoth
studi
also
employ
analyz
alter
plasma
protein
due
sarscov
infect
thirtyeight
differ
plasma
protein
sar
patient
identifi
associ
acut
phase
protein
one
advantag
gel
resolut
sinc
resolv
mani
protein
simultan
protein
detect
greater
ng
one
spot
current
techniqu
routin
appli
parallel
quantit
express
profil
larg
set
complex
protein
mixtur
whole
cell
lysat
addit
produc
map
intact
protein
reflect
chang
protein
express
level
differ
isoform
ptm
fact
great
advantag
methodolog
capabl
studi
protein
undergon
form
ptm
phosphoryl
glycosyl
limit
proteolysi
detect
visual
gel
appear
distinct
spot
train
horizont
andor
vertic
axi
gel
contrast
method
includ
lcbase
method
perform
analysi
peptid
molecular
weight
pi
inform
lost
stabl
isotop
label
requir
quantit
analysi
although
gel
electrophoresi
standard
technolog
suffer
sever
problem
may
limit
util
includ
issu
reproduc
well
inabl
separ
hydrophob
protein
poorli
solubl
although
use
ipg
strip
increas
reproduc
variou
problem
separ
remain
streak
poor
focus
variabl
occurr
gap
although
allow
high
resolut
individu
spot
singl
spot
may
correspond
singl
protein
sinc
protein
comigr
singl
spot
gel
furthermor
requir
milligram
quantiti
protein
reflect
low
sensit
method
enhanc
util
enrich
sampl
lowabund
protein
improv
method
requir
enrich
includ
prefraction
sampl
well
sensit
detect
quantit
method
use
altern
method
includ
laser
captur
microdissect
heterogen
tissu
studi
mention
previous
resolut
problem
overcom
narrow
ph
rang
allow
greater
focus
howev
reduc
ph
rang
ief
lead
elimin
larg
number
protein
may
inform
compar
hundr
protein
spot
across
gel
imag
taken
larg
number
differ
sampl
extrem
timeconsum
even
special
softwar
reason
although
electrophoresi
promis
tool
practic
clinic
applic
challeng
develop
techniqu
system
capabl
autom
high
throughput
high
sensit
multidimension
lcmsm
involv
solut
proteolysi
complex
mixtur
protein
fraction
highperform
liquid
chromatographi
hplc
peptid
analyz
tandem
ms
consist
two
phase
first
phase
peptid
chromatograph
fraction
electrospray
ioniz
produc
mass
spectrum
characterist
molecular
weight
peptid
sampl
second
phase
first
mass
analyz
instrument
use
select
singl
h
ion
mixtur
transmit
collis
chamber
peptid
undergo
collis
argon
atom
suffer
fragment
result
fragment
ion
transfer
second
analyz
separ
accord
mass
end
result
mass
spectrum
contain
ion
characterist
sequenc
amino
acid
select
peptid
mixtur
extrem
complex
onlin
reversephas
lc
use
concentr
separ
peptid
sequenc
ms
onlin
capillari
lcmsm
system
consist
convent
hplc
pump
transfer
tube
precolumn
flow
splitter
liquid
junction
reversephas
microcapillari
column
tandem
mass
spectromet
two
studi
use
lcmsm
identifi
differenti
protein
express
hivor
hcvinfect
cell
first
studi
tradit
hplc
ion
exchang
reversephas
column
coupl
ultrasensit
ion
trap
ms
employ
pumferi
et
al
identifi
protein
uniqu
mdm
identifi
protein
present
mdm
lysat
microsequenc
second
studi
use
normal
hepatocyt
immort
human
hepatocyt
induc
express
entir
hcv
orf
two
differ
cell
type
label
isotop
light
c
stimul
heavi
c
control
cell
reagent
call
isotopecod
affin
tag
icat
two
differenti
label
sampl
combin
digest
trypsin
digest
peptid
separ
strong
cationexchang
chromatographi
affin
purifi
avidin
cartridg
subject
lcesimsm
studi
led
identif
uniqu
protein
could
use
marker
diseas
progress
advantag
includ
autom
sampl
applic
abil
switch
column
sensit
method
abl
identifi
protein
low
level
addit
method
extens
use
determin
drug
hormon
level
human
serum
make
promis
tool
detect
diseas
prognosi
marker
proteom
analysi
provid
inform
protein
abund
gel
level
compar
stain
intens
howev
peptid
mixtur
analyz
directli
lcmsm
techniqu
origin
quantit
inform
lost
reason
one
drawback
use
lcmsm
depend
incorpor
stabl
isotop
label
quantit
proteom
analysi
involv
addit
chemic
ident
form
analyt
contain
stabl
heavi
isotop
eg
h
c
n
etc
sampl
selditof
proteom
technolog
aim
quantit
analysi
protein
mixtur
techniqu
reli
use
trap
surfac
allow
differenti
captur
protein
base
intrins
properti
protein
identifi
protein
crude
sampl
without
need
initi
separ
step
small
amount
sampl
directli
appli
biochip
coat
specif
chemic
matric
hydrophob
cation
anion
specif
biochem
materi
includ
dna
fragment
purifi
protein
bound
protein
analyz
ms
obtain
either
protein
fingerprint
amino
acid
sequenc
interfac
tandem
ms
seldi
proteinchip
approach
employ
studi
protein
profil
cell
infect
virus
includ
sever
acut
respiratori
syndrom
coronaviru
sarscov
chronic
hepat
b
viru
infect
chb
sar
viral
respiratori
ill
caus
sarscov
sar
recogn
global
threat
march
first
appear
southern
china
novemb
http
wwwcdcgov
current
serolog
method
use
laboratori
diagnosi
sar
fail
guarante
earli
diagnosi
sinc
base
detect
antibodi
produc
day
onset
symptom
elisabas
antigen
detect
test
offer
high
specif
reproduc
lack
sensit
contrari
pcrbase
method
includ
revers
transcriptionpcr
lack
sensit
specif
reason
need
develop
diagnost
methodolog
detect
sar
onset
symptom
allow
specif
prevent
treatment
measur
sar
accord
recent
studi
selditof
seem
promis
approach
studi
protein
profil
uniqu
sar
sera
acut
sar
patient
healthi
donor
examin
identifi
serum
marker
could
distinguish
sar
nonsar
patient
studi
analysi
spectra
accur
classifi
sar
specimen
accur
classifi
control
nonsar
addit
classif
algorithm
success
distinguish
acut
sar
type
infect
high
precis
approach
also
employ
discoveri
diagnost
proteom
signatur
sera
patient
chb
liver
fibrosi
cirrhosi
result
show
serum
proteom
featur
form
uniqu
fingerprint
fibrosi
correl
differ
stage
fibrosi
minim
fibrosi
cirrhosi
anoth
studi
evalu
protein
fingerprint
mdm
cell
lysat
directli
appli
two
type
protein
chip
weak
cation
exchang
reversephas
hydrophob
interact
wash
remov
unbound
protein
bound
protein
ioniz
molecular
masscharg
ratio
determin
use
tof
analysi
analysi
obtain
profil
show
distinct
pattern
uninfect
infect
mdm
seldi
proteinchip
approach
allow
highthroughput
protein
analysi
crude
protein
mixtur
without
need
separ
step
sensit
sinc
take
advantag
analyt
capac
ms
combin
novel
surfac
chemistri
provid
phenotyp
fingerprint
complex
mixtur
sampl
requir
dramat
reduc
approach
employ
ms
pumferi
et
al
readout
attomolar
femtomolar
concentr
protein
detect
addit
reproduc
greater
techniqu
gel
protein
extrem
pi
identifi
condit
problemat
normal
gel
electrophoresi
condit
final
greater
sensit
accuraci
lowmolecularweight
protein
kda
use
seldi
especi
kda
particularli
troublesom
gel
method
need
robust
algorithm
ensur
specif
profil
distinguish
pattern
diseas
healthi
individu
high
accuraci
take
account
variat
profil
healthi
individu
well
person
varieti
differ
infect
differ
time
period
cours
ill
two
addit
drawback
approach
follow
ident
protein
discov
ii
absolut
intens
peak
measur
relationship
abund
peak
peak
low
abund
mask
abund
one
addit
method
employ
direct
analysi
tissu
biolog
fluid
maldi
main
drawback
approach
preferenti
detect
protein
lower
molecular
mass
difficulti
determin
ident
protein
owe
ptm
obscur
correspond
measur
predict
mass
protein
microarray
reli
highthroughput
amplif
predict
orf
use
genespecif
primer
follow
vivo
homolog
recombin
express
vector
protein
express
escherichia
colibas
cellfre
vitro
transcriptiontransl
system
protein
product
unpurifi
reaction
print
directli
onto
nitrocellulos
microarray
without
purif
approach
use
determin
complet
antigenspecif
humor
immunerespons
profil
infect
human
anim
vaccinia
viru
proteom
contain
individu
viral
protein
print
chip
clone
express
chip
use
determin
antibodi
profil
serum
vacciniavirusimmun
human
primat
mice
develop
produc
protein
microarray
rapid
method
day
gene
comprehens
scan
humor
immun
respons
vaccin
infect
individu
gener
complet
proteom
technic
challeng
one
problem
amplif
long
gene
furthermor
express
protein
heterolog
system
effici
techniqu
also
take
account
ptm
viral
protein
express
bacteria
lastli
express
e
coli
might
lead
fold
problem
protein
proteom
analysi
cellular
protein
sampl
began
develop
page
later
develop
twodimension
gel
electrophoresi
techniqu
allow
separ
protein
base
size
page
charg
size
method
howev
allow
direct
identif
protein
band
indirect
method
western
blot
specif
antibodi
requir
identificationa
slow
labori
process
howev
combin
varieti
mass
spectrometr
method
page
identif
larger
number
protein
becom
possibl
method
proven
invalu
further
variou
avenu
viral
research
proteom
analysi
virus
includ
identif
protein
viru
particl
character
virushost
proteinprotein
interact
analysi
serum
protein
biomark
diseas
one
aspect
viral
proteom
character
viru
particl
viral
infect
cell
character
purifi
virion
led
identif
viral
protein
origin
identifi
virion
well
identif
cellular
protein
associ
purifi
viru
exampl
analysi
hcmv
viral
particl
identifi
addit
orf
previous
known
resid
virion
well
identif
cellular
protein
import
cellular
viral
protein
viral
replic
pathogenesi
await
analysi
addit
uniqu
polypeptid
identifi
correspond
previous
identifi
orf
illustr
fact
despit
intens
sequenc
analysi
sequenc
characterist
viral
promot
orf
still
entir
understood
analysi
viral
infect
cell
also
led
character
event
lead
ebvinduc
transform
identif
cellular
protein
induc
hivinfect
pumferi
et
al
macrophag
identif
cellular
protein
may
involv
aidsassoci
dementia
character
virushost
proteinprotein
interact
intens
studi
origin
studi
reli
analysi
interact
two
protein
use
yeast
twohybrid
system
identifi
new
protein
partner
protein
interest
studi
howev
quit
labor
intens
furthermor
yeast
twohybrid
system
suscept
falseposit
identif
use
identifi
multiprotein
complex
typic
take
account
possibl
ptm
may
influenc
protein
bind
proteom
analysi
howev
use
identifi
multiprotein
complex
use
analysi
infect
cell
take
account
ptm
occur
infect
cell
proteom
analysi
infect
cell
result
identif
cellular
protein
may
mediat
hsv
repress
cellular
protein
synthesi
identif
cellular
viral
protein
hsv
dna
replic
furthermor
analysi
hiv
tat
htlv
tax
proteom
identifi
member
chromatin
remodel
complex
compon
viral
transactiv
multiprotein
complex
mani
studi
allow
understand
viru
transcript
replic
transform
addit
studi
may
lead
identif
uniqu
drug
target
exampl
ptefb
complex
shown
critic
hiv
gene
express
hivinfect
cell
uniqu
sensit
transcript
suppress
effect
ptefb
inhibitor
flavopiridol
number
virus
caus
agent
cancer
includ
ebv
hepat
b
viru
hepat
c
viru
hcv
hcv
major
caus
increas
incid
liver
cancer
develop
countri
though
event
lead
transform
well
understood
recent
infecti
cell
cultur
model
hcv
avail
lack
cell
cultur
model
prevent
systemat
analysi
chang
induc
hcv
infect
altern
approach
studi
hcv
transform
comparison
liver
tissu
hepatomaderiv
cell
line
analysi
singl
viru
host
proteinprotein
interact
analysi
addit
hcv
protein
infect
cell
provid
addit
insight
natur
viru
abil
caus
cancer
one
aspect
viral
proteom
interest
physician
analysi
serum
protein
biomark
diseas
studi
perform
patient
infect
sarscov
hiv
hcv
hbv
use
varieti
approach
method
use
follow
ms
lcmsm
seldi
proteinchip
protein
microarray
method
advantag
disadvantag
gel
electrophoresi
allow
resolut
greater
protein
speci
use
quantit
analysi
express
reflect
chang
ptm
identif
isoform
howev
sever
issu
gel
electrophoresi
lack
reproduc
difficulti
detect
hydrophob
protein
low
sensit
inabl
use
highthroughput
method
analyz
larg
number
sampl
lcm
advantag
solubil
major
protein
autom
abil
switch
column
sensit
howev
abil
quantifi
chang
protein
level
lost
lcm
seldi
proteinchip
uniqu
allow
differenti
separ
complex
protein
mixtur
base
chemic
characterist
hydrophob
charg
result
decreas
complex
sampl
analyz
howev
seldi
consid
softion
method
result
obtain
pattern
protein
peak
identif
peptid
mass
ensur
specif
peak
profil
particular
diseas
state
robust
algorithm
need
lastli
protein
microarray
develop
determin
immun
respons
viral
infect
method
requir
express
print
orf
pathogen
crosslink
solid
support
protein
microarray
would
allow
rapid
diagnosi
particular
viral
infect
howev
express
complet
proteom
challeng
task
protein
express
bacteria
potenti
import
ptm
lost
protein
may
properli
fold
serum
complex
mixtur
protein
domin
two
proteinsalbumin
immunoglobulin
ig
abund
protein
mean
analysi
serum
potenti
biomark
diseas
requir
either
sensit
method
separ
albumin
ig
serum
sever
albumin
andor
ig
deplet
method
develop
resolv
issu
pieper
et
al
develop
seri
chromatograph
column
separ
immunoglobulin
base
affin
protein
g
well
column
contain
antibodi
specif
individu
protein
albumin
fibrinogen
transferrin
column
success
deplet
serum
sampl
respect
protein
use
sever
column
significantli
decreas
complex
sampl
analyz
addit
mixedb
column
develop
allow
simultan
separ
sever
protein
would
allow
autom
process
sampl
similar
approach
develop
biorad
affigel
blue
deplet
sampl
albumin
enhanc
detect
protein
sampl
affigel
blue
affin
hydrophob
aromat
steric
activ
bind
site
protein
although
product
high
affin
albumin
may
bind
protein
well
limit
use
lastli
baussant
et
al
develop
peptidebas
approach
deplet
albumin
approach
base
fact
although
protein
g
affin
fc
region
igg
also
bind
albumin
less
specif
baussant
et
al
modifi
peptid
protein
g
much
higher
affin
albumin
significantli
specif
deplet
serum
albumin
howev
hydrophob
protein
ie
apolipoprotein
also
captur
despit
rel
small
size
virus
fairli
complex
encod
dozen
protein
mani
protein
posttransl
modifi
interact
viral
host
protein
function
identifi
protein
encod
virus
protein
interact
greatli
understand
viral
replic
pathogenesi
proteom
approach
greatli
facilit
studi
lastli
abil
diagnos
cancer
viral
infect
earli
stage
allow
earli
treatment
reduc
morbid
mortal
associ
diseas
proteom
analysi
biolog
marker
serum
allow
earli
noninvas
diagnosi
cancer
although
good
reliabl
method
avail
analysi
serum
proteom
abund
protein
ie
albumin
ig
low
abund
mani
protein
requir
method
separ
highabund
protein
instrument
method
enough
sensit
identifi
protein
low
concentr
becom
increasingli
clear
field
proteom
may
requir
better
robust
separ
method
sensit
instrument
unbias
bioinformat
tool
histor
provid
rapid
mean
separ
thousand
protein
cell
tissu
sampl
one
run
although
power
research
tool
enthusiast
appli
mani
field
biomed
research
accur
analysi
interpret
data
provid
mani
challeng
sever
analysi
step
need
convert
larg
amount
noisi
data
obtain
reliabl
interpret
biolog
inform
goal
analysi
step
includ
accur
protein
detect
quantif
consist
compar
visual
method
well
identif
differenti
express
protein
sampl
run
differ
gel
achiev
goal
systemat
error
geometr
distort
gel
must
correct
use
computerassist
method
wide
rang
comput
softwar
develop
gener
consensu
exist
standard
data
analysi
protocol
search
new
diagnost
therapeut
target
use
studi
differenti
express
peptid
protein
variou
diseas
entiti
howev
usual
requir
larg
amount
start
materi
timeconsum
reveal
fraction
protein
present
given
sampl
recent
proteinchip
technolog
coupl
bioinformat
gain
consider
attent
techniqu
use
selditofm
screen
protein
sourc
put
diseas
biomark
spectrum
kda
sever
studi
provid
evid
proteinchip
technolog
capabl
detect
earlystag
cancer
uniqu
cancerspecif
proteom
fingerprint
sensit
specif
reach
far
beyond
wellestablish
serumbas
tumor
marker
howev
rapid
diagnosi
test
seldi
technolog
still
detect
natur
amino
acid
biomark
ptm
consist
reproduc
manner
clearli
technolog
lcmsm
lcfticr
far
sensit
better
defin
composit
biomark
final
recent
much
effort
gone
concept
labonachip
chip
involv
microns
channel
embed
glass
silicon
chip
attempt
made
carri
twodimension
gelbas
experi
chip
microchip
abl
carri
microfluid
experi
develop
eg
nanogen
inc
diagnoswiss
calip
technolog
faster
accur
convent
gel
technolog
technolog
made
compat
would
offer
immens
research
potenti
especi
promis
advanc
detect
lowabund
protein
ptm
chapter
discuss
latest
new
proteom
find
relat
import
viral
infect
known
human
includ
hcmv
hsv
ebv
kshv
hiv
htlv
hbv
hcv
sar
infect
mani
instanc
seen
mere
descript
viral
infect
host
cell
proteom
howev
data
date
descript
natur
studi
correl
phenotyp
infect
patholog
drug
treatment
although
case
investig
found
new
enzym
target
marker
ie
sarscov
seriou
attempt
made
function
identifi
signific
patholog
viru
mainli
field
viral
proteom
earli
stage
develop
much
confirmatori
inform
would
requir
anim
human
model
studi
current
either
progress
need
develop
near
futur
therefor
new
field
function
viral
proteom
develop
industri
academ
set
address
issu
relat
function
biomark
drugresist
virus
hostpathogen
relat
pertain
diseas
prognosi
treatment
decis
monitor
respons
therapi
anoth
challeng
consider
mix
infect
seen
aid
patient
may
vari
clade
infect
seven
clade
close
genet
distinct
genotyp
also
coinfect
virus
hcv
kshv
complic
identifi
biomark
patient
instanc
anim
model
never
properli
address
current
literatur
enough
awar
variou
compart
patient
bench
bedsid
practic
therefor
better
flow
inform
use
solid
epidemiolog
data
follow
better
diagnost
viral
etiolog
would
allow
meaning
identif
proteom
biomark
seen
patient
multipl
biomark
would
serv
invalu
tool
multipl
drug
treatment
better
control
mix
infect
final
issu
frontend
purif
collect
test
materi
perhap
import
aspect
sampl
prepar
current
variou
method
util
standard
separ
techniqu
remov
abund
protein
prior
ms
ie
remov
highabund
protein
better
visual
lowabund
protein
sigmaaldrich
kit
howev
case
remov
protein
may
fact
compromis
detect
biomark
partner
sinc
mani
instanc
viral
infect
lead
overexpress
abund
protein
actin
keratin
tubulin
cyclophilin
vimentin
hsp
among
other
therefor
futur
attempt
identif
biomark
would
defin
highand
lowabund
protein
also
partner
possibl
modif
